[Anabolic treatment combined with an antimitotic agent in order to prevent leukocyte decrease].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D007970:Leukopenia / Q000209:etiology*; D009277:Nandrolone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009277:Nandrolone; D003520:Cyclophosphamide
Traitement anabolisant associé à un antimitotique dans le but de prévenir la chute des leucocytes sanguins.